• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用倍半萜内酯作为具有抗被忽视传染病潜在活性的新型结构来源的计算机辅助药物设计

Computer-Aided Drug Design Using Sesquiterpene Lactones as Sources of New Structures with Potential Activity against Infectious Neglected Diseases.

作者信息

Herrera Acevedo Chonny, Scotti Luciana, Feitosa Alves Mateus, Formiga Melo Diniz Margareth De Fátima, Scotti Marcus Tullius

机构信息

Post-Graduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, 58051-900 João Pessoa, PB, Brazil.

出版信息

Molecules. 2017 Jan 3;22(1):79. doi: 10.3390/molecules22010079.

DOI:10.3390/molecules22010079
PMID:28054952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6155652/
Abstract

This review presents an survey to the biological importance of sesquiterpene lactones (SLs) in the fight against four infectious neglected tropical diseases (NTDs)-leishmaniasis, schistosomiasis, Chagas disease, and sleeping sickness-as alternatives to the current chemotherapies that display several problems such as low effectiveness, resistance, and high toxicity. Several studies have demonstrated the great potential of some SLs as therapeutic agents for these NTDs and the relationship between the protozoal activities with their chemical structure. Recently, Computer-Aided Drug Design (CADD) studies have helped increase the knowledge of SLs regarding their mechanisms, the discovery of new lead molecules, the identification of pharmacophore groups and increase the biological activity by employing in silico tools such as molecular docking, virtual screening and Quantitative-Structure Activity Relationship (QSAR) studies.

摘要

本综述对倍半萜内酯(SLs)在对抗四种被忽视的热带传染病(NTDs)——利什曼病、血吸虫病、恰加斯病和昏睡病——中的生物学重要性进行了调查,将其作为目前化疗方法的替代方案,目前的化疗方法存在有效性低、耐药性和高毒性等诸多问题。多项研究已证明某些SLs作为这些NTDs治疗药物的巨大潜力,以及原生动物活性与其化学结构之间的关系。最近,计算机辅助药物设计(CADD)研究有助于增加对SLs作用机制的了解,发现新的先导分子,识别药效基团,并通过使用分子对接、虚拟筛选和定量构效关系(QSAR)研究等计算机工具提高其生物活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11a/6155652/11355a959c65/molecules-22-00079-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11a/6155652/38c812e2410a/molecules-22-00079-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11a/6155652/4f8bc5feae2a/molecules-22-00079-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11a/6155652/6a8a1e96af9e/molecules-22-00079-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11a/6155652/11355a959c65/molecules-22-00079-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11a/6155652/38c812e2410a/molecules-22-00079-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11a/6155652/4f8bc5feae2a/molecules-22-00079-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11a/6155652/6a8a1e96af9e/molecules-22-00079-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11a/6155652/11355a959c65/molecules-22-00079-g004a.jpg

相似文献

1
Computer-Aided Drug Design Using Sesquiterpene Lactones as Sources of New Structures with Potential Activity against Infectious Neglected Diseases.利用倍半萜内酯作为具有抗被忽视传染病潜在活性的新型结构来源的计算机辅助药物设计
Molecules. 2017 Jan 3;22(1):79. doi: 10.3390/molecules22010079.
2
High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.用于发现抗三种被忽视热带病(人类非洲锥虫病、利什曼病和恰加斯病)的天然产物药物的高通量筛选平台。
J Biomol Screen. 2015 Jan;20(1):82-91. doi: 10.1177/1087057114555846. Epub 2014 Oct 20.
3
In Silico Studies Designed to Select Sesquiterpene Lactones with Potential Antichagasic Activity from an In-House Asteraceae Database.计算机模拟研究旨在从内部菊科数据库中筛选具有潜在抗恰加斯病活性的倍半萜内酯。
ChemMedChem. 2018 Mar 20;13(6):634-645. doi: 10.1002/cmdc.201700743. Epub 2018 Feb 6.
4
Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review.寻找治疗恰加斯病、利什曼病和血吸虫病的药物:综述。
Int J Antimicrob Agents. 2020 Apr;55(4):105906. doi: 10.1016/j.ijantimicag.2020.105906. Epub 2020 Jan 25.
5
Quantitative structure--antiprotozoal activity relationships of sesquiterpene lactones.倍半萜内酯的定量结构-抗寄生虫活性关系
Molecules. 2009 Jun 8;14(6):2062-76. doi: 10.3390/molecules14062062.
6
Therapeutic Potential of Flavonoid Derivatives for Certain Neglected Tropical Diseases.类黄酮衍生物在某些被忽视热带病中的治疗潜力。
Curr Drug Targets. 2022;23(7):680-682. doi: 10.2174/1389450123666220309093827.
7
Infectious diseases. Overcoming neglect of kinetoplastid diseases.传染病。克服对动质体疾病的忽视。
Science. 2015 May 29;348(6238):974-6. doi: 10.1126/science.aaa3683. Epub 2015 May 28.
8
The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.重新审视动基体化疗:现有药物、最新进展及未来展望。
Curr Med Chem. 2010;17(33):4027-51. doi: 10.2174/092986710793205345.
9
The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases.天然产物在抗被忽视热带病药物发现与开发中的作用
Molecules. 2016 Dec 31;22(1):58. doi: 10.3390/molecules22010058.
10
Selection of antileishmanial sesquiterpene lactones from SistematX database using a combined ligand-/structure-based virtual screening approach.采用基于配体和结构的联合虚拟筛选方法从 SistematX 数据库中筛选抗利什曼原虫的倍半萜内酯。
Mol Divers. 2021 Nov;25(4):2411-2427. doi: 10.1007/s11030-020-10139-6. Epub 2020 Sep 9.

引用本文的文献

1
Evaluation of the Antileishmanial Activity of Some Benzimidazole Derivatives Using In Vitro and In Silico Techniques.利用体外和计算机模拟技术评估某些苯并咪唑衍生物的抗利什曼原虫活性
Vet Sci. 2025 Jun 5;12(6):550. doi: 10.3390/vetsci12060550.
2
Identification of Microbial-Based Natural Products as Potential CYP51 Inhibitors for Eumycetoma Treatment: Insights from Molecular Docking, MM-GBSA Calculations, ADMET Analysis, and Molecular Dynamics Simulations.鉴定基于微生物的天然产物作为治疗足菌肿的潜在CYP51抑制剂:来自分子对接、MM-GBSA计算、ADMET分析和分子动力学模拟的见解
Pharmaceuticals (Basel). 2025 Apr 20;18(4):598. doi: 10.3390/ph18040598.
3

本文引用的文献

1
Recent developments and future prospects in the treatment of visceral leishmaniasis.内脏利什曼病治疗的最新进展与未来前景
Ther Adv Infect Dis. 2016 Jun;3(3-4):98-109. doi: 10.1177/2049936116646063. Epub 2016 Apr 22.
2
Chagas Disease: A Solvable Problem, Ignored.恰加斯病:一个可解决却被忽视的问题。
Trends Mol Med. 2016 Oct;22(10):835-838. doi: 10.1016/j.molmed.2016.07.008. Epub 2016 Aug 11.
3
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness.蛋白酶体抑制用于治疗利什曼病、恰加斯病和昏睡病。
Anthelmintic Potential of Conjugated Long-Chain Fatty Acids Isolated from the Bioluminescent Mushroom .
从发光蘑菇中分离出的共轭长链脂肪酸的驱虫潜力
J Nat Prod. 2025 Feb 28;88(2):255-261. doi: 10.1021/acs.jnatprod.4c00546. Epub 2025 Jan 4.
4
Machine-Learning- and Structure-Based Virtual Screening for Selecting Cinnamic Acid Derivatives as DHFR-TS Inhibitors.基于机器学习和结构的虚拟筛选,选择肉桂酸衍生物作为 DHFR-TS 抑制剂。
Molecules. 2023 Dec 28;29(1):179. doi: 10.3390/molecules29010179.
5
Natural-Product-Based Solutions for Tropical Infectious Diseases.天然产物在热带传染病防治中的应用。
Clin Microbiol Rev. 2021 Dec 15;34(4):e0034820. doi: 10.1128/CMR.00348-20. Epub 2021 Sep 8.
6
Identification of Kaurane-Type Diterpenes as Inhibitors of Leishmania Pteridine Reductase I.鉴定贝壳杉烷型二萜为利什曼原虫喋呤还原酶 I 的抑制剂。
Molecules. 2021 May 21;26(11):3076. doi: 10.3390/molecules26113076.
7
Sesquiterpene Lactones and Diterpenes: Promising Therapeutic Candidates for Infectious Diseases, Neoplasms and Other Chronic Disorders.倍半萜内酯和二萜类化合物:传染病、肿瘤及其他慢性疾病的潜在治疗候选物。
Molecules. 2021 Feb 26;26(5):1251. doi: 10.3390/molecules26051251.
8
Colombian Contributions Fighting Leishmaniasis: A Systematic Review on Antileishmanials Combined with Chemoinformatics Analysis.哥伦比亚在抗利什曼病方面的贡献:联合化学生物信息学分析的抗利什曼原虫药物的系统评价。
Molecules. 2020 Dec 3;25(23):5704. doi: 10.3390/molecules25235704.
9
Need for sustainable approaches in antileishmanial drug discovery.抗利什曼原虫药物发现中可持续方法的必要性。
Parasitol Res. 2019 Oct;118(10):2743-2752. doi: 10.1007/s00436-019-06443-2. Epub 2019 Aug 31.
10
An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.一种来源于白皮松的四环三萜,含有甾体样核芯和内酯侧链,可在体外抑制肝片吸虫和曼氏血吸虫的存活。
Int J Parasitol Drugs Drug Resist. 2018 Dec;8(3):465-474. doi: 10.1016/j.ijpddr.2018.10.009. Epub 2018 Oct 26.
Nature. 2016 Sep 8;537(7619):229-233. doi: 10.1038/nature19339. Epub 2016 Aug 8.
4
QSAR-Driven Discovery of Novel Chemical Scaffolds Active against Schistosoma mansoni.基于定量构效关系驱动发现对曼氏血吸虫有活性的新型化学骨架
J Chem Inf Model. 2016 Jul 25;56(7):1357-72. doi: 10.1021/acs.jcim.6b00055. Epub 2016 Jun 16.
5
Molecular mechanisms of endocrine and metabolic disruption: An in silico study on antitrypanosomal natural products and some derivatives.内分泌和代谢紊乱的分子机制:抗锥虫天然产物及其一些衍生物的计算机模拟研究。
Toxicol Lett. 2016 Jun 11;252:29-41. doi: 10.1016/j.toxlet.2016.04.013. Epub 2016 Apr 16.
6
Schistosomiasis Prevalence and Intensity of Infection in Latin America and the Caribbean Countries, 1942-2014: A Systematic Review in the Context of a Regional Elimination Goal.1942 - 2014年拉丁美洲和加勒比国家的血吸虫病流行率与感染强度:在区域消除目标背景下的系统评价
PLoS Negl Trop Dis. 2016 Mar 23;10(3):e0004493. doi: 10.1371/journal.pntd.0004493. eCollection 2016 Mar.
7
Mode of Action of the Sesquiterpene Lactones Psilostachyin and Psilostachyin C on Trypanosoma cruzi.倍半萜内酯类化合物psilostachyin和psilostachyin C对克氏锥虫的作用机制
PLoS One. 2016 Mar 3;11(3):e0150526. doi: 10.1371/journal.pone.0150526. eCollection 2016.
8
Schistosomiasis elimination by 2020 or 2030?到2020年还是2030年消除血吸虫病?
Int J Parasitol. 2016 Jun;46(7):385-8. doi: 10.1016/j.ijpara.2016.01.004. Epub 2016 Feb 21.
9
Active sesquiterpene lactones against Leishmania amazonensis and Leishmania braziliensis.抗亚马逊利什曼原虫和巴西利什曼原虫的活性倍半萜内酯
Nat Prod Res. 2016 Nov;30(22):2611-2615. doi: 10.1080/14786419.2015.1126260. Epub 2016 Jan 12.
10
Current drug therapy and pharmaceutical challenges for Chagas disease.恰加斯病的当前药物治疗与制药挑战
Acta Trop. 2016 Apr;156:1-16. doi: 10.1016/j.actatropica.2015.12.017. Epub 2015 Dec 30.